Modified protein selection strategy based on Escherichia coli’s Hitchhiker transport and validation through selection of nanobodies targeting bovine interferon gamma

The Escherichia coli hitchhiker co-translocation mechanism has been adapted as a screening platform known as Functional Ligand-binding Identification by Tat-based Recognition of Associating Proteins (FLI-TRAP) for identifying and isolating interacting proteins. Traditional FLI-TRAP systems utilize either monocistronic or bicistronic expression constructs. However, in the context of selecting single-domain antibody fragments, or ‘nanobodies’ (Nbs), specific to bovine interferon-gamma (bIFN-γ), the monocistronic system produces insufficient expression levels while the original bicistronic system is prone to false positives due to potential structural rearrangements that allow antibiotic resistance independent of Nb–antigen binding. To overcome these limitations, we have modified an improved bicistronic FLI-TRAP system that reduces the rate of false positives and enhances the fidelity of the selection process. This optimized system was validated through isolating anti-bIFN-γ Nbs from a fully synthetic yeast display library. Candidate Nbs were first enriched using magnetic-activated cell sorting (MACS), followed by screening via the improved FLI-TRAP assay. The two best clones, B7 and N5, displayed specific binding to bIFN-γ, with dissociation constants (KD) of 81.6 nM and 575 nM, respectively. Further characterization revealed that B7 exhibited high specificity, low polyreactivity, and effective detection of bIFN-γ in bovine plasma samples, compared with the BOVIGAM kit, a commercially approved and widely used diagnostic tool for bovine tuberculosis. This study demonstrates the utility of the improved bicistronic FLI-TRAP system as a reliable, scalable, and cost-effective platform for selecting high-affinity Nbs. The system offers a promising alternative for developing Nb-based diagnostic kits, which are particularly suited for use in resource-limited settings.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-03-13
DOI
https://doi.org/10.1038/s41598-026-43280-7
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Modified protein selection strategy based on Escherichia coli’s Hitchhiker transport and validation through selection of nanobodies targeting bovine interferon gamma

Pinpunya Riangrungroj, Suwitchaya Sirimanakul, Lueacha Tabtimmai, Nonth Submunkongtawee et al.
Scientific Reports
Monoclonal and Polyclonal Antibodies Research
article

Modified protein selection strategy based on Escherichia coli’s Hitchhiker transport and validation through selection of nanobodies targeting bovine interferon gamma

Pinpunya Riangrungroj, Suwitchaya Sirimanakul, Lueacha Tabtimmai, Nonth Submunkongtawee, Jeerapond Leelawattanachai, Apisitt Thaiprayoon, Joseph D. Hurley, Kreeson Packthongsuk, Kiattawee Choowongkomon, Warisara Kasemsukwimol, Kittitat Jaengwang, Kwanpet Intasurat, Dujduan Waraho-Zhmayev, Andrew C. Kruse
article en

Abstract

The Escherichia coli hitchhiker co-translocation mechanism has been adapted as a screening platform known as Functional Ligand-binding Identification by Tat-based Recognition of Associating Proteins (FLI-TRAP) for identifying and isolating interacting proteins. Traditional FLI-TRAP systems utilize either monocistronic or bicistronic expression constructs. However, in the context of selecting single-domain antibody fragments, or ‘nanobodies’ (Nbs), specific to bovine interferon-gamma (bIFN-γ), the monocistronic system produces insufficient expression levels while the original bicistronic system is prone to false positives due to potential structural rearrangements that allow antibiotic resistance independent of Nb–antigen binding. To overcome these limitations, we have modified an improved bicistronic FLI-TRAP system that reduces the rate of false positives and enhances the fidelity of the selection process. This optimized system was validated through isolating anti-bIFN-γ Nbs from a fully synthetic yeast display library. Candidate Nbs were first enriched using magnetic-activated cell sorting (MACS), followed by screening via the improved FLI-TRAP assay. The two best clones, B7 and N5, displayed specific binding to bIFN-γ, with dissociation constants (KD) of 81.6 nM and 575 nM, respectively. Further characterization revealed that B7 exhibited high specificity, low polyreactivity, and effective detection of bIFN-γ in bovine plasma samples, compared with the BOVIGAM kit, a commercially approved and widely used diagnostic tool for bovine tuberculosis. This study demonstrates the utility of the improved bicistronic FLI-TRAP system as a reliable, scalable, and cost-effective platform for selecting high-affinity Nbs. The system offers a promising alternative for developing Nb-based diagnostic kits, which are particularly suited for use in resource-limited settings.

Scientific Reports
National Science and Technology Development Agency (TH), Harvard University (US), Kasetsart University (TH), National Nanotechnology Center (TH), Boston VA Research Institute (US), Department of Livestock Development (TH), King Mongkut's University of Technology Thonburi (TH), King Mongkut's University of Technology North Bangkok (TH), National Center for Genetic Engineering and Biotechnology (TH)
Zero hunger
Openalex Percentile: Top 23%
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.